Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print

Roche Names R&D Head



Published January 15, 2013
Related Searches: R&D Pharma Development
John C. Reed, M.D., Ph.D., has been appointed head of Roche Pharma Research and Early Development (pRED) and member of the corporate executive committee, effective April 2, 2013. He will be based in Basel, reporting to Severin Schwan, chief executive officer of the Roche Group. 
 
Prior to joining the company, he was chief executive officer at Sanford-Burnham Medical Research Institute in La Jolla, CA. He is a leading biomedical researcher with a focus on cancer, neuroprotection, autoimmunity, and other diseases. Dr. Reed has authored several hundred medical research publications and is among the world’s most highly cited scientists for his research contributions. 
 
Mr. Schwan said, “We are delighted to welcome John Reed to Roche, who has led one of the world’s top laboratory-based medical research institutes. With his broad scientific and medical background he is ideally positioned to drive Roche’s strategy of translating a better understanding of disease mechanisms into promising therapeutics.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On